Classics in Chemical Neuroscience: Medetomidine
Open Access
- 15 October 2024
- journal article
- review article
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 15 (21) , 3874-3883
Abstract
Medetomidine is an FDA-approved α2-adrenoreceptor (α2-AR) agonist used as a veterinary sedative due to its analgesic, sedative, and anxiolytic properties. While it is marketed for veterinary use as a racemic mixture under the brand name Domitor, the pharmacologically active enantiomer, dexmedetomidine, is approved for sedation and analgesia in the hospital setting. Medetomidine has recently been detected in the illicit drug supply alongside fentanyl, xylazine, cocaine, and heroin, producing pronounced sedative effects that are not reversed by naloxone. The pharmacological effects along with the low cost of supply and lack of regulation for medetomidine has made it a target for misuse. Since 2022, medetomidine has been found as an adulterant in samples of seized drugs, as well as in toxicological analyses of patients admitted to the emergency department after suspected overdoses across several U.S. states and Canada. This Review will discuss the history, chemistry, structure-activity relationships, drug metabolism and pharmacokinetics (DMPK), pharmacology, and emergence of medetomidine as an adulterant in drug mixtures in the context of the current opioid drug crisis.Keywords
This publication has 62 references indexed in Scilit:
- Naloxone ineffective on medetomidine, vet drugAlcoholism & Drug Abuse Weekly, 2024
- Clinical Pharmacokinetics and Pharmacodynamics of DexmedetomidineClinical Pharmacokinetics, 2017
- Dexmedetomidine: A Review of Its Use for Sedation in the Intensive Care SettingDrugs, 2015
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Influence of Cardiac Output on Dexmedetomidine PharmacokineticsJournal of Pharmaceutical Sciences, 2000
- [3H]Dexmedetomidine, an α2-adrenoceptor agonist, detects a novel imidazole binding site in adult rat spinal cordEuropean Journal of Pharmacology, 1996
- Central α2-adrenoceptors are highly stereoselective for dexmedetomidine, the dextro enantiomer of medetomidineEuropean Journal of Pharmacology, 1991
- Characterization of the selectivity, specificity and potency of medetomidine as an α2-adrenoceptor agonistEuropean Journal of Pharmacology, 1988
- Structure—Activity Relationships for alpha-2 Adrenergic Receptor Agonists and Antagonists1988
- ?-Adrenoceptor activity of arylalkylimidazoles is improved by?-methylation and impaired by?-hydroxylationNaunyn-Schmiedeberg's Archives of Pharmacology, 1986